# Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites

> **NCT00501722** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 110 (actual)

## Conditions studied

- Ascites
- Liver Cirrhosis

## Interventions

- **DRUG:** satavaptan (SR121463B)

## Key facts

- **NCT ID:** NCT00501722
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2009-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501722, "Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00501722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*